Your search returned 2 results.

Results
	1.	Antitumor activity of HKI-272, an orally active, irreversible inhibitor of the HER-2 tyrosine kinase. [electronic resource] by Rabindran, Sridhar K Discafani, Carolyn M Rosfjord, Edward C Baxter, Michelle Floyd, M Brawner Golas, Jonathan Hallett, William A Johnson, Bernard D Nilakantan, Ramaswamy Overbeek, Elsebe Reich, Marvin F Shen, Ru Shi, Xiaoqing Tsou, Hwei-Ru Wang, Yu-Fen Wissner, Allan Producer: 20040726 In: Cancer research vol. 64 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	Synthesis and structure-activity relationships of 6,7-disubstituted 4-anilinoquinoline-3-carbonitriles. The design of an orally active, irreversible inhibitor of the tyrosine kinase activity of the epidermal growth factor receptor (EGFR) and the human epidermal growth factor receptor-2 (HER-2). [electronic resource] by Wissner, Allan Overbeek, Elsebe Reich, Marvin F Floyd, M Brawner Johnson, Bernard D Mamuya, Nellie Rosfjord, Edward C Discafani, Carolyn Davis, Rachel Shi, Xiaoqing Rabindran, Sridhar K Gruber, Brian C Ye, Fei Hallett, William A Nilakantan, Ramaswamy Shen, Ru Wang, Yu-Fen Greenberger, Lee M Tsou, Hwei-Ru Producer: 20030204 In: Journal of medicinal chemistry vol. 46 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)

Refine your search